Tsunemasa Irie
Sumitomo Chemical
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tsunemasa Irie.
Neuroscience Letters | 1992
Satoshi Yamamoto; Toshiki Yoshimine; Toshiaki Fujita; Ryotaro Kuroda; Tsunemasa Irie; Keiji Tsukaguchi-Cho Fujioka; Toru Hayakawa
Very recently, contradictory results were presented as to the effects of exogenous nerve growth factor (NGF) on the hippocampal delayed neuronal necrosis following transient ischemia. In the present study, we administered a large amount of NGF with the atelocollagen mini-pellet system, measured the local NGF contents, and evaluated the effect of this neurotrophic factor on the postischemic hippocampal pyramidal cells in gerbils. We concluded that the exogenous NGF, when given continuously at sufficient concentrations, prevents pyramidal cell damage. The possible cause of discrepancy in previous studies is discussed.
Neuroscience Letters | 1991
Mann Xu; Yasuharu Nakamura; Toshifumi Yamamoto; Kazuichi Natori; Tsunemasa Irie; Hiroya Utsumi; Takeshi Kato
A U-shaped dialysis cannula was implanted into rat frontal cortex, hippocampus and striatum, and after 1 day for surgical recovery the cannula was perfused with Ringers solution without any acetylcholinesterase (AChE) inhibitor under freely moving conditions. With a highly sensitive assay method for acetylcholine (ACh), the basal ACh content in the dialysates were detectable in those brain regions for several hours. The basal levels in the frontal cortex, hippocampus and striatum were 82 +/- 9, 72 +/- 4, 70 +/- 8 fmol/20 microliters (mean +/- S.E.M.), respectively. When SM-10888, a novel AChE inhibitor and putative therapeutic drug for Alzheimers disease, was injected intraperitoneally, ACh in the dialysate of the cortex increased in a dose-dependent manner. Changes in the levels of hippocampal and striatal ACh release evoked by SM-10888 were similar to, but smaller than, that in the cortex. These data suggest that since the present assay method is able to determine in vivo basal ACh release in the dialysate without any AChE inhibitor, it is possible to study the effect of a novel drug such as SM-10888 in the brain regions.
Archive | 1991
Naoki Tohdoh; Shinichiro Tojo; Shinichi Kojima; Yasuyuki Ueki; Toshio Nishihara; Nobuyuki Fukushima; Tsunemasa Irie; Keiichi Ono; Hideo Agui; Kosei Ojika
Archive | 1990
Toru Hayakawa; Toshiki Yoshimine; Keiji Fujioka; Yoshihiro Takada; Yoshio Sasaki; Tsunemasa Irie; Nobuyuki Fukushima
Archive | 1992
Toru Hayakawa; Toshiki Yoshimine; Hiromu Aza Gotan Yamamoto; Akira Sato; Tsunemasa Irie; Keiji Tsukaguchi-Cho Fujioka; Yoshihiro Senriyama-Nishi Takada; Yoshio Tsunoe-Cho Sasaki
Japanese Journal of Pharmacology | 1990
Kazuichi Natori; Yuko Okazaki; Tsunemasa Irie; Junki Katsube
Japanese Journal of Pharmacology | 1990
Yuko Okazaki; Kazuichi Natori; Tsunemasa Irie; Junki Katsube
Japanese Journal of Pharmacology | 1987
Etsuro Sato; Tsunemasa Irie; Junki Katsube
Archive | 1983
Atsuyuki Kojima; Tsunemasa Irie; Shuichi Harada; Yoshito Kameno; Junki Katsube; Hisao Yamamoto
Archive | 1993
Kosei Ojika; Keiichi Ono; Yoshiharu Ikeda; Yasuyuki Ueki; Tsunemasa Irie; Nobuyuki Fukushima